| Trial Identifier: | D133HR00028 |
| Sponsor: | AstraZeneca |
| Start Date: | May 2023 |
| Primary Completion Date: | July 2024 |
| Study Completion Date: | July 2024 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Russia | Arkhangelsk, Russia |
| Russia | Barnaul, Russia |
| Russia | Belgorod, Russia |
| Russia | Chelyabinsk, Russia |
| Russia | Chita, Russia |
| Russia | Irkutsk, Russia |
| Russia | Kaluga, Russia |
| Russia | Kemerovo, Russia |
| Russia | Khabarovsk, Russia |
| Russia | Khanty-Mansiysk, Russia |
| Russia | Kostroma, Russia |
| Russia | Krasnodar, Russia |
| Russia | Krasnoyarsk, Russia |
| Russia | Maykop, Russia |
| Russia | Nizhny Novgorod, Russia |
| Russia | Omsk, Russia |
| Russia | Ryazan, Russia |
| Russia | Severodvinsk, Russia |
| Russia | Sochi, Russia |
| Russia | Surgut, Russia |
| Russia | Tomsk, Russia |
| Russia | Tver, Russia |
| Russia | Ufa, Russia |
| Russia | Ulan-Ude, Russia |
| Russia | Volgograd, Russia |
| Russia | Yaroslavl, Russia |
| Russia | Yuzhno-Sakhalinsk, Russia |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company